These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 39398331

  • 1. Association between serum insulin-like growth factor-1 and bone mineral density in patients with type 2 diabetes.
    Zhao Q, Li Y, Zhang Q, Zhang M, Ban B.
    Front Endocrinol (Lausanne); 2024; 15():1457050. PubMed ID: 39398331
    [Abstract] [Full Text] [Related]

  • 2. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Kanazawa I, Notsu M, Miyake H, Tanaka K, Sugimoto T.
    Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
    [Abstract] [Full Text] [Related]

  • 3. Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes.
    Lv F, Cai X, Zhang R, Zhou L, Zhou X, Han X, Ji L.
    Osteoporos Int; 2021 Jun; 32(6):1165-1173. PubMed ID: 33415372
    [Abstract] [Full Text] [Related]

  • 4. Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis.
    Kashii M, Kamatani T, Nagayama Y, Miyama A, Tsuboi H, Ebina K.
    Osteoporos Int; 2023 Mar; 34(3):563-572. PubMed ID: 36585509
    [Abstract] [Full Text] [Related]

  • 5. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
    Jing Y, Wang X, Yu J, Wang X, Zhou Y, Tao B, Sun L, Liu J, Zhao H.
    J Diabetes; 2020 Jun; 12(6):426-437. PubMed ID: 31778286
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K.
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [Abstract] [Full Text] [Related]

  • 7. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study.
    Barrett-Connor E, Goodman-Gruen D.
    J Bone Miner Res; 1998 Aug; 13(8):1343-9. PubMed ID: 9718204
    [Abstract] [Full Text] [Related]

  • 8. Non-linear association of atherogenic index of plasma with bone mineral density a cross-sectional study.
    Xu B, Ma G, Yang L, Chen X, Bian B, Yang B, Zhang D, Qin X, Zhu L, Yin H, Wei X, Feng M.
    Lipids Health Dis; 2024 Jun 12; 23(1):181. PubMed ID: 38867213
    [Abstract] [Full Text] [Related]

  • 9. Low serum concentrations of insulin-like growth factor I are associated with femoral bone loss in a population-based sample of postmenopausal women.
    Seck T, Scheidt-Nave C, Leidig-Bruckner G, Ziegler R, Pfeilschifter J.
    Clin Endocrinol (Oxf); 2001 Jul 12; 55(1):101-6. PubMed ID: 11453958
    [Abstract] [Full Text] [Related]

  • 10. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ, Oh KW, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Park CY, Choi MG, Yoo HJ, Park SW.
    J Bone Miner Metab; 2004 Jul 12; 22(4):392-8. PubMed ID: 15221500
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov 12; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 12. Association between serum insulin-like growth factor 1 and osteoporosis risk in Parkinson's disease: a cross-sectional study.
    Geng C, Chen C.
    Neurol Sci; 2024 Nov 12; 45(11):5291-5296. PubMed ID: 38898339
    [Abstract] [Full Text] [Related]

  • 13. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
    Scacchi M, Danesi L, Cattaneo A, Sciortino G, Radin R, Ambrogio AG, Vitale G, D'Angelo E, Mirra N, Zanaboni L, Arvigo M, Boschetti M, Ferone D, Marzullo P, Baldini M, Cassinerio E, Cappellini MD, Persani L, Cavagnini F.
    Endocrine; 2016 Aug 12; 53(2):551-7. PubMed ID: 26825070
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG.
    Calcif Tissue Int; 2002 Jan 12; 70(1):22-9. PubMed ID: 11907704
    [Abstract] [Full Text] [Related]

  • 15. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
    Nabipour I, Larijani B, Beigi S, Jafari SM, Amiri M, Assadi M, Pazoki R, Amiri Z, Sanjdideh Z.
    Menopause; 2008 Jan 12; 15(5):934-9. PubMed ID: 18451743
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
    Krassas GE, Papadopoulou P, Koliakos G, Konstantinidis T, Kalothetou K.
    Arch Androl; 2003 Jan 12; 49(3):191-9. PubMed ID: 12746097
    [Abstract] [Full Text] [Related]

  • 17. Correlation between bone mineral density and type 2 diabetes mellitus in elderly men and postmenopausal women.
    Luo W, Li X, Zhou Y, Xu D, Qiao Y.
    Sci Rep; 2024 Jul 02; 14(1):15078. PubMed ID: 38956260
    [Abstract] [Full Text] [Related]

  • 18. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
    Zhao C, Liu G, Zhang Y, Xu G, Yi X, Liang J, Yang Y, Liang J, Ma C, Ye Y, Yu M, Qu X.
    J Clin Lab Anal; 2020 Apr 02; 34(4):e23112. PubMed ID: 31733013
    [Abstract] [Full Text] [Related]

  • 19. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.
    Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA.
    Clin Endocrinol (Oxf); 2004 Apr 02; 60(4):491-9. PubMed ID: 15049965
    [Abstract] [Full Text] [Related]

  • 20. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis.
    Huang N, Zhou J, Wang W, Wang Q, Tang Y, Sun Y, Wang D, Chen S.
    Clin Endocrinol (Oxf); 2018 May 02; 88(5):659-664. PubMed ID: 29394455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.